Swixx Biopharma sp. z o.o.

Market research and public opinion polling

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-09-21
Share capital
5,000.00 PLN
Registered address
ul. Prosta 51, 00-838 Warszawa, Poland
Electronic delivery address
AE:PL-85414-55303-DCDAR-21

Financials

Revenue history (in m)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

From the notes

Current income tax (CIT due)$200,253

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 439 days for 2021). 2 of 6 audited by a statutory auditor.

  • 202503/07/2026
  • 202410/07/2025
  • 202304/07/2024
  • 202227/09/2023
  • 202127/09/2023
  • 202001/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 2.2%
City · Warszawa3,520 / 56,729
Top 6.2%
Voivodeship · Mazowieckie4,879 / 76,892
Top 6.3%
Country · Poland17,481 / 297,069
Top 5.9%

Results vs industry

Revenue
This companyUSD 11.29mMedianUSD 112.93kAverageUSD 1.39m
Net profit
This companyUSD 535.23kMedianUSD 3.34kAverageUSD 117.93k
Operating costs
This companyUSD 10.50mMedianUSD 100.06kAverageUSD 1.26m
Assets
This companyUSD 4.50mMedianUSD 91.62kAverageUSD 1.28m

Authorized Representatives

Michał Adrian Opuchlik age 54 – Attorney-in-fact
Jean-Michel Patrick Lespinasse – Management Board Member
Jerzy Mikołaj Woyciechowski age 51 – Attorney-in-fact
Petr Pípal – Management Board Member

Manner of representation

In the case of a multi-member management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to represent the company.

Ownership

OwnerSharesShare valueStake
Swixx Biopharma Ag
100$1,350.62100%

Beneficial owners

Person

Capital group

The company belongs to the Swixx Biopharma AG (Switzerland) group, which is its direct owner.

Bank accounts

Registered as a VAT taxpayer on 2019-02-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Gemius S.A.
IQS sp. z o.o.
PLUM Research S.A.
Difference sp. z o.o.
Target Point sp. z o.o.
Wiserabbit sp. z o.o.
Centrum Badań Marketingowych Indicator sp. z o.o.
Tgth sp. z o.o.
Maison & Partners sp. z o.o.
Cxstream sp. z o.o.

Change history

DateEvent
2023-07-03Address change
2020-07-01Address change
2019-06-03Name change
2018-12-18Address change
2018-09-21Entered in the register

FAQ

Last updated: 2026-11-12